-
1
-
-
22744455811
-
Emerging guidelines for the use of NSAID therapy to optimize cataract surgery and patient care
-
O'Brien TP. Emerging guidelines for the use of NSAID therapy to optimize cataract surgery and patient care. Curr Med Res Opin. 2005;21:1131-1137.
-
(2005)
Curr Med Res Opin
, vol.21
, pp. 1131-1137
-
-
O'Brien, T.P.1
-
2
-
-
33044507658
-
Efficacy of topical Voltaren in reducing the incidence of postoperative cystoid macular edema
-
McColgin AZ, Raizman MB. Efficacy of topical Voltaren in reducing the incidence of postoperative cystoid macular edema. Invest Ophthalmol Vis Sci. 1999;40:S289.
-
(1999)
Invest Ophthalmol Vis Sci
, vol.40
-
-
McColgin, A.Z.1
Raizman, M.B.2
-
3
-
-
0033757470
-
Ketorolac versus prednisolone versus combination therapy in the treatment of acute pseudophakic cystoid macular edema
-
Heier JS, Topping TM, Baumann W, et al. Ketorolac versus prednisolone versus combination therapy in the treatment of acute pseudophakic cystoid macular edema. Ophthalmol. 2000;107:2034-2038.
-
(2000)
Ophthalmol
, vol.107
, pp. 2034-2038
-
-
Heier, J.S.1
Topping, T.M.2
Baumann, W.3
-
4
-
-
33750336217
-
-
Senju Pharmaceutical Company, Ltd, Osaka, Japan
-
Bronuck® package insert. Senju Pharmaceutical Company, Ltd, Osaka, Japan, 2003.
-
(2003)
Bronuck® Package Insert
-
-
-
7
-
-
6344260351
-
Involvement of cyclooxygenase-2 in rat models of conjunctivitis
-
Oka T, Shearer TR, Azuma M. Involvement of cyclooxygenase-2 in rat models of conjunctivitis. Curr Eye Res. 2004;29:27-34.
-
(2004)
Curr Eye Res
, vol.29
, pp. 27-34
-
-
Oka, T.1
Shearer, T.R.2
Azuma, M.3
-
8
-
-
17544398602
-
Non-steroidal anti-inflammatory drugs and ocular inflammation
-
Guex-Crosier Y. Non-steroidal anti-inflammatory drugs and ocular inflammation. Klin Montasl Augenheilkd. 2001;218:305-308.
-
(2001)
Klin Montasl Augenheilkd
, vol.218
, pp. 305-308
-
-
Guex-Crosier, Y.1
-
9
-
-
0002953558
-
Lipid-derived autacoids: Eicosanoids and platelet-activating factor
-
Hardman JG, Limbird LE, Molinoff PB, et al, eds. New York, NY: McGraw-NeHill
-
Campbell WB, Halushka PV. Lipid-derived autacoids: eicosanoids and platelet-activating factor. In: Hardman JG, Limbird LE, Molinoff PB, et al, eds. Goodman & Gilman's The Pharmacological Basis of Therapeutics. 9th ed. New York, NY: McGraw-NeHill; 1996:601-616.
-
(1996)
Goodman & Gilman's the Pharmacological Basis of Therapeutics. 9th Ed.
, pp. 601-616
-
-
Campbell, W.B.1
Halushka, P.V.2
-
10
-
-
0021733791
-
Anti-inflammatory agents. 3. Synthesis and pharmacological evaluation of 2-amino-3benzoylphenylacetic acid and analogues
-
Walsh DA, Moran HW, Shamblee DA, et al. Anti-inflammatory agents. 3. Synthesis and pharmacological evaluation of 2-amino-3benzoylphenylacetic acid and analogues. J Med Chem. 1984;11:1379-1388.
-
(1984)
J Med Chem
, vol.11
, pp. 1379-1388
-
-
Walsh, D.A.1
Moran, H.W.2
Shamblee, D.A.3
-
11
-
-
0027581690
-
QSAR and conformational analysis of the anti-inflammatory agent amfenac and analogues
-
Ruiz J, Lopez M, Mila J, et al. QSAR and conformational analysis of the anti-inflammatory agent amfenac and analogues. J Comput-Aided Molec Design. 1993;7:183-198.
-
(1993)
J Comput-Aided Molec Design
, vol.7
, pp. 183-198
-
-
Ruiz, J.1
Lopez, M.2
Mila, J.3
-
12
-
-
0023230366
-
The analgesic and antiinflammatory activity and pharmacologic properties of bromfenac
-
Sancilio LF, Nolan JC, Wagner LE, et al. The analgesic and antiinflammatory activity and pharmacologic properties of bromfenac. Arzneimittelforschung. 1987;37:513-519.
-
(1987)
Arzneimittelforschung
, vol.37
, pp. 513-519
-
-
Sancilio, L.F.1
Nolan, J.C.2
Wagner, L.E.3
-
13
-
-
0003979209
-
-
ISTA Pharmaceuticals, Inc.
-
Data on file. ISTA Pharmaceuticals, Inc.
-
Data on File
-
-
-
14
-
-
33750303458
-
Topically administrable compositions containing 3-benzoylphenylacetic acid derivatives for treatment of ophthalmic inflammatory disorders
-
Alcon Laboratories, Inc., assignee. U.S. Patent 5,475,034. December. 12
-
Yanni JM, Graff G, Hellberg MR. Topically administrable compositions containing 3-benzoylphenylacetic acid derivatives for treatment of ophthalmic inflammatory disorders. Alcon Laboratories, Inc., assignee. U.S. Patent 5,475,034. December. 12, 1995.
-
(1995)
-
-
Yanni, J.M.1
Graff, G.2
Hellberg, M.R.3
-
15
-
-
33745685717
-
Comparison of cyclooxygenase inhibitory activity and ocular anti-inflammatory effects of ketorolac tromethamine and bromfenac sodium
-
Waterbury LD, Silliman D, Jolas T. Comparison of cyclooxygenase inhibitory activity and ocular anti-inflammatory effects of ketorolac tromethamine and bromfenac sodium. Curr Med Res Opin. 2006;22:1133-1140.
-
(2006)
Curr Med Res Opin
, vol.22
, pp. 1133-1140
-
-
Waterbury, L.D.1
Silliman, D.2
Jolas, T.3
-
16
-
-
33750312738
-
14C-bromfenac ophthalmic solution
-
San Francisco, CA, March 17-22, Abstract P227
-
14C-bromfenac ophthalmic solution. Proceedings of the American Society of Cataract & Refractive Surgery (ASCRS) Meeting, San Francisco, CA, March 17-22, 2006. Abstract P227.
-
(2006)
Proceedings of the American Society of Cataract & Refractive Surgery (ASCRS) Meeting
-
-
Bakalyan, G.A.1
Deshmukh, H.M.2
Patterson, H.3
-
17
-
-
48349101855
-
Use of non-steroidal anti-inflammatory agents in combination with compounds that have PF prostaglandin agonist activity to treat glaucoma and ocular hypertension
-
Alcon Laboratories, Inc., assignee. U.S. Patent 6,342,524 B1. January. 29
-
Helberg MR, Nixon JC. Use of non-steroidal anti-inflammatory agents in combination with compounds that have PF prostaglandin agonist activity to treat glaucoma and ocular hypertension. Alcon Laboratories, Inc., assignee. U.S. Patent 6,342,524 B1. January. 29, 2002.
-
(2002)
-
-
Helberg, M.R.1
Nixon, J.C.2
-
19
-
-
33750312737
-
Pharmacokinetic profile of topically applied bromfenac sodium ophthalmic solution 0.1% in subjects undergoing cataract surgery
-
Ft. Lauderdale, FL, April 30-May 4
-
Ogawa T, Miyake K, McNamara TR, et al. Pharmacokinetic profile of topically applied bromfenac sodium ophthalmic solution 0.1% in subjects undergoing cataract surgery. Proceedings of the Association for Research in Vision and Ophthalmology (ARVO) Annual Meeting, Ft. Lauderdale, FL, April 30-May 4, 2006. A687.
-
(2006)
Proceedings of the Association for Research in Vision and Ophthalmology (ARVO) Annual Meeting
-
-
Ogawa, T.1
Miyake, K.2
McNamara, T.R.3
-
20
-
-
33750332012
-
Effect of bromfenac sodium ophthalmic solution on inflammation following intraocular lens implantation
-
Masuda K, Fukado Y, Shimizu H, et al. Effect of bromfenac sodium ophthalmic solution on inflammation following intraocular lens implantation. Ganka Rinsho Iho (Jpn Rev Clin Ophthalmol). 1997;91:745-750.
-
(1997)
Ganka Rinsho Iho (Jpn Rev Clin Ophthalmol)
, vol.91
, pp. 745-750
-
-
Masuda, K.1
Fukado, Y.2
Shimizu, H.3
-
21
-
-
0037594952
-
Effect of bromfenac ophthalmic solution on ocular inflammation and corneal epithelial barrier function following cataract surgery
-
Kawaguchi T, Kida T, Nemoto S, et al. Effect of bromfenac ophthalmic solution on ocular inflammation and corneal epithelial barrier function following cataract surgery. Folia Ophthalmol Jpn. 2003;54:276-279.
-
(2003)
Folia Ophthalmol Jpn
, vol.54
, pp. 276-279
-
-
Kawaguchi, T.1
Kida, T.2
Nemoto, S.3
-
22
-
-
0042031376
-
Efficacy and adverse effects of bromfenac ophthalmic solution following cataract surgery
-
Takamatsu F, Shiroyama N, Saito Y, et al. Efficacy and adverse effects of bromfenac ophthalmic solution following cataract surgery. Rinsho Ganka (Jpn J Clin Ophthalmol). 2003;57:1233-1237.
-
(2003)
Rinsho Ganka (Jpn J Clin Ophthalmol)
, vol.57
, pp. 1233-1237
-
-
Takamatsu, F.1
Shiroyama, N.2
Saito, Y.3
-
24
-
-
33750333043
-
Integrated results from two phase III studies of topical Xibrom™ 0.1%, an investigational NSAID for post-cataract surgery inflammation
-
New Orleans, LA, October 24
-
Stewart RH, Walters TR, Cooke DL, et al. Integrated results from two phase III studies of topical Xibrom™ 0.1%, an investigational NSAID for post-cataract surgery inflammation. Proceedings of the 108th Annual American Academy of Ophthalmology Meeting, New Orleans, LA, October 24, 2004.
-
(2004)
Proceedings of the 108th Annual American Academy of Ophthalmology Meeting
-
-
Stewart, R.H.1
Walters, T.R.2
Cooke, D.L.3
-
25
-
-
33750309025
-
Topical Xibrom 0.1%, an investigational NSAID for post-cataract surgery inflammation, markedly decreases inflammation
-
Washington, DC, April 15-20
-
Donnenfeld ED, Holland EJ, Stewart RH, et al. Topical Xibrom 0.1%, an investigational NSAID for post-cataract surgery inflammation, markedly decreases inflammation. Proceedings of the American Society of Cataract & Refractive Surgery (ASCRS) Meeting, Washington, DC, April 15-20, 2005.
-
(2005)
Proceedings of the American Society of Cataract & Refractive Surgery (ASCRS) Meeting
-
-
Donnenfeld, E.D.1
Holland, E.J.2
Stewart, R.H.3
-
26
-
-
33750292433
-
Topical Xibrom™ 0.09% significantly and rapidly decreased post-cataract surgery inflammation and reduced ocular pain
-
(E-abstract 791)
-
Donnenfeld ED, Holland EJ, Stewart RH, et al. Topical Xibrom™ 0.09% significantly and rapidly decreased post-cataract surgery inflammation and reduced ocular pain (E-abstract 791). Invest Ophthalmol Vis Sci. 2005;46.
-
(2005)
Invest Ophthalmol Vis Sci
, pp. 46
-
-
Donnenfeld, E.D.1
Holland, E.J.2
Stewart, R.H.3
-
27
-
-
84863429986
-
Topical Xibrom™ 0.09% significantly reduced ocular pain following cataract surgery
-
Ft. Lauderdale, FL, April 30-May 4
-
Seward MS, Cooke DL, Grillone LR, et al. Topical Xibrom™ 0.09% significantly reduced ocular pain following cataract surgery. Proceedings of the Association for Research in Vision and Ophthalmology (ARVO) Annual Meeting, Ft. Lauderdale, FL, April 30-May 4, 2006. A679.
-
(2006)
Proceedings of the Association for Research in Vision and Ophthalmology (ARVO) Annual Meeting
-
-
Seward, M.S.1
Cooke, D.L.2
Grillone, L.R.3
-
28
-
-
0002734554
-
Nonsteroidal anti-inflammatory drugs
-
Tasman W, ed. Philadelphia: Lippincott
-
Flach AJ. Nonsteroidal anti-inflammatory drugs. In: Tasman W, ed. Duane's Foundations in Clinical Ophthalmology. Philadelphia: Lippincott; 1994:1-32.
-
(1994)
Duane's Foundations in Clinical Ophthalmology
, pp. 1-32
-
-
Flach, A.J.1
-
29
-
-
3242772245
-
Prevention of miosis during cataract surgery by topical bromfenac sodium
-
Ohara K, Ohkubo A, Miyamoto T, et al. Prevention of miosis during cataract surgery by topical bromfenac sodium. Rinsho Ganka (Jpn J Clin Ophthalmol). 2004;58:1325-1328.
-
(2004)
Rinsho Ganka (Jpn J Clin Ophthalmol)
, vol.58
, pp. 1325-1328
-
-
Ohara, K.1
Ohkubo, A.2
Miyamoto, T.3
-
30
-
-
12144264233
-
Comparison of 0.1% bromfenac sodium and 0.1% pemirolast potassium for the treatment of allergic conjunctivitis
-
Miyake-Kashima M, Takano Y, Tanaka M, et al. Comparison of 0.1% bromfenac sodium and 0.1% pemirolast potassium for the treatment of allergic conjunctivitis. Jpn J Ophthalmol. 2004;48:587-590.
-
(2004)
Jpn J Ophthalmol
, vol.48
, pp. 587-590
-
-
Miyake-Kashima, M.1
Takano, Y.2
Tanaka, M.3
-
31
-
-
33750289768
-
Effect of bromfenac sodium (AHR-10282B) eye drops on anterior uveitis
-
Usui M, Masuda K. Effect of bromfenac sodium (AHR-10282B) eye drops on anterior uveitis. Ganka Rinsho Iho (J Rev Clin Ophthalmol). 1997;91:39-44.
-
(1997)
Ganka Rinsho Iho (J Rev Clin Ophthalmol)
, vol.91
, pp. 39-44
-
-
Usui, M.1
Masuda, K.2
-
32
-
-
0346098252
-
Treatment of acute pseudophakic cystoid macular edema: Diclofenac versus ketorolac
-
Rho DS. Treatment of acute pseudophakic cystoid macular edema: diclofenac versus ketorolac. J Cataract Refract Surg. 2003;29:2378-2384.
-
(2003)
J Cataract Refract Surg
, vol.29
, pp. 2378-2384
-
-
Rho, D.S.1
-
33
-
-
85121054141
-
Bromfenac 0.09% versus diclofenac sodium 0.1% versus ketorolac tromethamine 0.5% in the treatment of acute pseudophakic cystoid macular edema
-
Ft. Lauderdale, FL, April 30-May 4
-
Rho DS, Soll SM, Markovitz BJ. Bromfenac 0.09% versus diclofenac sodium 0.1% versus ketorolac tromethamine 0.5% in the treatment of acute pseudophakic cystoid macular edema. Proceedings of the Association for Research in Vision and Ophthalmology (ARVO) Annual Meeting, Ft. Lauderdale, FL, April 30-May 4, 2006. A5211.
-
(2006)
Proceedings of the Association for Research in Vision and Ophthalmology (ARVO) Annual Meeting
-
-
Rho, D.S.1
Soll, S.M.2
Markovitz, B.J.3
-
34
-
-
33750289015
-
A prospective randomized comparison of bromfenac with ketorolac for the treatment of patients with reduced visual acuity following glaucoma surgery
-
Charleston, SC, March 2-5
-
Solish, AM. A prospective randomized comparison of bromfenac with ketorolac for the treatment of patients with reduced visual acuity following glaucoma surgery. Proceedings of the 16th Annual American Glaucoma Society (AGS) Meeting, Charleston, SC, March 2-5, 2006.
-
(2006)
Proceedings of the 16th Annual American Glaucoma Society (AGS) Meeting
-
-
Solish, A.M.1
-
35
-
-
0035029473
-
Keratitis, ulceration, and perforation associated with topical non-steroidal anti-inflammatory drugs
-
Guidera AC, Luchs JI, Udell IJ. Keratitis, ulceration, and perforation associated with topical non-steroidal anti-inflammatory drugs. Ophthalmol. 2001;108:936-944.
-
(2001)
Ophthalmol
, vol.108
, pp. 936-944
-
-
Guidera, A.C.1
Luchs, J.I.2
Udell, I.J.3
-
36
-
-
0035320753
-
Corneal complications associated with topical ophthalmic use of nonsteroidal anti-inflammatory drugs
-
Congdon NG, Schein OD, von Kulata P, et al. Corneal complications associated with topical ophthalmic use of nonsteroidal anti-inflammatory drugs. J Cataract Refract Surg. 2001;27:622-631.
-
(2001)
J Cataract Refract Surg
, vol.27
, pp. 622-631
-
-
Congdon, N.G.1
Schein, O.D.2
Von Kulata, P.3
-
37
-
-
0035696994
-
Ketorolac in the era of cyclo-oxygenase-2 selective nonsteroidal anti-inflammatory drugs: A systematic review of efficacy, side effects, and regulatory issues
-
Macario A, Lipman AG. Ketorolac in the era of cyclo-oxygenase-2 selective nonsteroidal anti-inflammatory drugs: a systematic review of efficacy, side effects, and regulatory issues. Pain Med. 2001;2:336-351.
-
(2001)
Pain Med
, vol.2
, pp. 336-351
-
-
Macario, A.1
Lipman, A.G.2
-
38
-
-
33750373190
-
Clinical effect of bromfenac sodium ophthalmic solution on inflammation following intraocular lens implantation: Optimal frequency of instillation
-
Shimizu H, Matsuda K, Fukado Y, et al. Clinical effect of bromfenac sodium ophthalmic solution on inflammation following intraocular lens implantation: optimal frequency of instillation. Atarashii Ganka. 1997;14:309-316.
-
(1997)
Atarashii Ganka
, vol.14
, pp. 309-316
-
-
Shimizu, H.1
Matsuda, K.2
Fukado, Y.3
-
39
-
-
0030908278
-
Effect of bromfenac sodium on post-operative inflammation - A double-masked trial
-
Masuda K, Fukado Y, Shimizu H, et al. Effect of bromfenac sodium on post-operative inflammation - a double-masked trial. Folia Ophthalmol Japan. 1997;48:560-569.
-
(1997)
Folia Ophthalmol Japan
, vol.48
, pp. 560-569
-
-
Masuda, K.1
Fukado, Y.2
Shimizu, H.3
-
40
-
-
0030844272
-
Efficacy of bromfenac sodium ophthalmic solution for ocular surface inflammation - A double-masked controlled trial
-
Sawa M, Masuda K, Usui M, et al. Efficacy of bromfenac sodium ophthalmic solution for ocular surface inflammation - a double-masked controlled trial. Folia Ophthalmol Jpn. 1997;48:717-724.
-
(1997)
Folia Ophthalmol Jpn
, vol.48
, pp. 717-724
-
-
Sawa, M.1
Masuda, K.2
Usui, M.3
-
41
-
-
0003979209
-
-
ISTA Pharmaceuticals, Inc.
-
Data on file. ISTA Pharmaceuticals, Inc.
-
Data on File
-
-
-
42
-
-
0003979209
-
-
ISTA Pharmaceuticals, Inc.
-
Data on file. ISTA Pharmaceuticals, Inc.
-
Data on File
-
-
-
43
-
-
0003979209
-
-
ISTA Pharmaceuticals, Inc.
-
Data on file. ISTA Pharmaceuticals, Inc.
-
Data on File
-
-
-
44
-
-
33750312736
-
Post-marketing surveillance of bromfenac sodium (Bronuck®) ophthalmic solution
-
Kitao N, Shimoji H, Fukuda M. Post-marketing surveillance of bromfenac sodium (Bronuck®) ophthalmic solution. Atarashii Ganka (J of the Eye). 2005;22:1299-1308.
-
(2005)
Atarashii Ganka (J of the Eye)
, vol.22
, pp. 1299-1308
-
-
Kitao, N.1
Shimoji, H.2
Fukuda, M.3
-
45
-
-
0038459329
-
Two cases of corneal ulcer following instillation of bromfenac sodium ophthalmic solution
-
Mochizuki M, Nakagami T, Asai T. Two cases of corneal ulcer following instillation of bromfenac sodium ophthalmic solution. Rinsho Ganka (Jpn J Clin Ophthalmol). 2003;57:675-679.
-
(2003)
Rinsho Ganka (Jpn J Clin Ophthalmol)
, vol.57
, pp. 675-679
-
-
Mochizuki, M.1
Nakagami, T.2
Asai, T.3
-
46
-
-
33644839861
-
Three cases of corneal melting after instillation of a new nonsteroidal anti-inflammatory drug
-
Asai T, Nakagami T, Mochizuki M, et al. Three cases of corneal melting after instillation of a new nonsteroidal anti-inflammatory drug. Cornea. 2006;25:224-227.
-
(2006)
Cornea
, vol.25
, pp. 224-227
-
-
Asai, T.1
Nakagami, T.2
Mochizuki, M.3
-
47
-
-
0003979209
-
-
ISTA Pharmaceuticals, Inc.
-
Data on file. ISTA Pharmaceuticals, Inc.
-
Data on File
-
-
-
48
-
-
33750377045
-
Investigation of liver toxicity following topical treatment with Xibrom™ 0.01%, an NSAID for post-cataract surgery inflammation
-
Washington, DC, April 15-20
-
Shiffman ML, Donnenfeld ED, Holland ED, et al. Investigation of liver toxicity following topical treatment with Xibrom™ 0.01%, an NSAID for post-cataract surgery inflammation. Proceedings of the American Society of Cataract & Refractive Surgery (ASCRS) Meeting, Washington, DC, April 15-20, 2005.
-
(2005)
Proceedings of the American Society of Cataract & Refractive Surgery (ASCRS) Meeting
-
-
Shiffman, M.L.1
Donnenfeld, E.D.2
Holland, E.D.3
-
49
-
-
0034760617
-
Evaluation and multivariate statistical analysis of factors influencing patient adherence to ophthalmic solutions
-
Ikeda H, Sato M, Tsukamoto H, et al. Evaluation and multivariate statistical analysis of factors influencing patient adherence to ophthalmic solutions. Yakugaku Zasshi. 2001;121:799-806.
-
(2001)
Yakugaku Zasshi
, vol.121
, pp. 799-806
-
-
Ikeda, H.1
Sato, M.2
Tsukamoto, H.3
-
50
-
-
0003979209
-
-
ISTA Pharmaceuticals, Inc.
-
Data on file. ISTA Pharmaceuticals, Inc.
-
Data on File
-
-
-
51
-
-
0003979209
-
-
ISTA Pharmaceuticals, Inc.
-
Data on file. ISTA Pharmaceuticals, Inc.
-
Data on File
-
-
-
52
-
-
33750320411
-
Anesthesia and ocular tolerability of topical non-steroidal anti-inflammatory drugs: A direct comparison between bromfenac and nepafenac
-
Ft. Lauderdale, FL, April 30-May 4
-
Maris PJ, Perry HD, Donnenfeld ED, et al. Anesthesia and ocular tolerability of topical non-steroidal anti-inflammatory drugs: A direct comparison between bromfenac and nepafenac. Proceedings of the Association for Research in Vision and Ophthalmology (ARVO) Annual Meeting, Ft. Lauderdale, FL, April 30-May 4, 2006. A4993.
-
(2006)
Proceedings of the Association for Research in Vision and Ophthalmology (ARVO) Annual Meeting
-
-
Maris, P.J.1
Perry, H.D.2
Donnenfeld, E.D.3
-
53
-
-
0036303314
-
Effect of topical diclofenac and ketorolac on patient discomfort and corneal sensitivity
-
Narvaez J, Kroll P, Guzek JP. Effect of topical diclofenac and ketorolac on patient discomfort and corneal sensitivity. J Refract Surgery. 2002;18:145-148.
-
(2002)
J Refract Surgery
, vol.18
, pp. 145-148
-
-
Narvaez, J.1
Kroll, P.2
Guzek, J.P.3
|